Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ESRRG-controlled downregulation of KCNN1 in primary sensory neurons is required for neuropathic pain
Huixing Wang, Wanhong Zuo, Xiaozhou Feng, Xiaodong Huo, Yingping Liang, Bing Wang, Dilip Sharma, Xiang Li, Bushra Yasin, Jiang-Hong Ye, Huijuan Hu, Yuan-Xiang Tao
Huixing Wang, Wanhong Zuo, Xiaozhou Feng, Xiaodong Huo, Yingping Liang, Bing Wang, Dilip Sharma, Xiang Li, Bushra Yasin, Jiang-Hong Ye, Huijuan Hu, Yuan-Xiang Tao
View: Text | PDF
Research Article Neuroscience

ESRRG-controlled downregulation of KCNN1 in primary sensory neurons is required for neuropathic pain

  • Text
  • PDF
Abstract

Peripheral nerve injury–induced neuronal hyperactivity in the dorsal root ganglion (DRG) participates in neuropathic pain. The calcium-activated potassium channel subfamily N member 1 (KCNN1) mediates action potential afterhyperpolarization (AHP) and gates neuronal excitability. However, the specific contribution of DRG KCNN1 to neuropathic pain is not yet clear. We report that chronic constriction injury (CCI) of the unilateral sciatic nerve or unilateral ligation of the fourth lumbar nerve produced the downregulation of Kcnn1 mRNA and KCNN1 protein in the injured DRG. This downregulation was partially attributed to a decrease in DRG estrogen-related receptor gamma (ESRRG), a transcription factor, which led to reduced binding to the Kcnn1 promoter. Rescuing this downregulation prevented CCI-induced decreases in total potassium voltage currents and AHP currents, reduced excitability in the injured DRG neurons, and alleviated CCI-induced development and maintenance of nociceptive hypersensitivities, without affecting locomotor function and acute pain. Mimicking the CCI-induced DRG KCNN1 downregulation resulted in augmented responses to mechanical, heat, and cold stimuli in naive mice. Our findings indicate that ESRRG-controlled downregulation of DRG KCNN1 is likely essential for the development and maintenance of neuropathic pain. Thus, KCNN1 may serve as a potential target for managing this disorder.

Authors

Huixing Wang, Wanhong Zuo, Xiaozhou Feng, Xiaodong Huo, Yingping Liang, Bing Wang, Dilip Sharma, Xiang Li, Bushra Yasin, Jiang-Hong Ye, Huijuan Hu, Yuan-Xiang Tao

×

Figure 5

Effects of mimicking the CCI-induced DRG KCNN1 downregulation on basal nociceptive thresholds in naive male mice.

Options: View larger image (or click on image) Download as PowerPoint
Effects of mimicking the CCI-induced DRG KCNN1 downregulation on basal n...
(A–C) Expression of Kcnn1 mRNA (A), KCNN1 protein (B), K2p1.1 protein (C), and Kv1.2 protein (C) in the ipsilateral L3/4 DRGs 7 days after microinjection of Kcnn1 siRNA (KCN si) or control scrambled siRNA (Scr si) into unilateral L3/4 DRGs. n = 3 biological repeats (6 mice)/group. **P < 0.01 by 2-tailed unpaired Student’s t test. (D–G) Paw withdrawal frequencies (PWF) in response to 0.07 g (D) and 0.4 g (E) von Frey filament stimuli and paw withdrawal latencies (PWL) to heat (F) and cold (G) stimuli on the ipsilateral and contralateral sides on the days as indicated after microinjection of Kcnn1 siRNA (KCN si) or control scrambled siRNA (Scr si) into unilateral L3/4 DRGs. n = 8 mice/group. **P < 0.01 versus the Scr si–microinjected group at the corresponding days on the ipsilateral side by 3-way ANOVA with repeated measures followed by post hoc Tukey test. (H and I) Expression of p-ERK1/2, total ERK1/2, GFAP (H), and Iba1 (I) in the ipsilateral L3/4 dorsal horn 7 days after microinjection of Kcnn1 siRNA (KCN si) or control scrambled siRNA (Scr si) into unilateral L3/4 DRGs. n = 3 biological repeats (6 mice)/group. **P < 0.01 by 2-tailed unpaired Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts